Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 325

1.

What weight loss treatment options do geriatric patients with overweight and obesity want to consider?

MacMillan M, Cummins K, Fujioka K.

Obes Sci Pract. 2016 Dec;2(4):477-482. doi: 10.1002/osp4.66.

2.

Method-of-use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity.

Halseth A, Shan K, Walsh B, Gilder K, Fujioka K.

Obesity (Silver Spring). 2016 Dec 27. doi: 10.1002/oby.21726. [Epub ahead of print]

PMID:
28026920
3.

Gestational age-dependency of height and body mass index trajectories during the first 3 years in Japanese small-for-gestational age children.

Maeyama K, Morioka I, Iwatani S, Fukushima S, Kurokawa D, Yamana K, Nishida K, Ohyama S, Fujioka K, Awano H, Taniguchi-Ikeda M, Nozu K, Nagase H, Nishimura N, Shirai C, Iijima K.

Sci Rep. 2016 Dec 9;6:38659. doi: 10.1038/srep38659.

4.

Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.

Iyer KR, Kunecki M, Boullata JI, Fujioka K, Joly F, Gabe S, Pape UF, Schneider SM, Virgili Casas MN, Ziegler TR, Li B, Youssef NN, Jeppesen PB.

JPEN J Parenter Enteral Nutr. 2016 Nov 22. pii: 0148607116680791. [Epub ahead of print]

PMID:
27875291
5.

Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers.

Fujioka K, O'Neil PM, Davies M, Greenway F, C W Lau D, Claudius B, Skjøth TV, Bjørn Jensen C, P H Wilding J.

Obesity (Silver Spring). 2016 Nov;24(11):2278-2288. doi: 10.1002/oby.21629.

6.

Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes.

O'Neil PM, Miller-Kovach K, Tuerk PW, Becker LE, Wadden TA, Fujioka K, Hollander PL, Kushner RF, Timothy Garvey W, Rubino DM, Malcolm RJ, Weiss D, Raum WJ, Salyer JL, Hermayer KL, Rost SL, Veliko JL, Sora ND.

Obesity (Silver Spring). 2016 Nov;24(11):2269-2277. doi: 10.1002/oby.21616.

PMID:
27804264
7.

Lorcaserin treatment allows for decreased number needed to treat for weight and glycemic parameters in week 12 responders with ≥5% weight loss.

Handelsman Y, Fain R, Wang Z, Li X, Fujioka K, Shanahan W.

Postgrad Med. 2016 Nov;128(8):740-746.

PMID:
27659698
8.

Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System.

Hwang SS, Takata MC, Fujioka K, Fuller W.

Med Devices (Auckl). 2016 Aug 17;9:291-9. doi: 10.2147/MDER.S106223. Review.

9.

Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management.

Fujioka K, Braverman-Panza J.

J Fam Pract. 2016 Jul;65(7 Suppl):S16-23.

PMID:
27565106
10.

Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide.

Fujioka K, Jeejeebhoy K, Pape UF, Li B, Youssef NN, Schneider SM.

JPEN J Parenter Enteral Nutr. 2016 Aug 9. pii: 0148607116663481. [Epub ahead of print]

PMID:
27507402
11.

Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates.

Seno T, Yamamoto A, Kukida Y, Hirano A, Kida T, Nakabayashi A, Fujioka K, Nagahara H, Fujii W, Murakami K, Oda R, Fujiwara H, Kohno M, Kawahito Y.

Springerplus. 2016 Jul 11;5(1):1056. doi: 10.1186/s40064-016-2704-5.

12.

Induction of Heme Oxygenase-1 Attenuates the Severity of Sepsis in a Non-Surgical Preterm Mouse Model.

Fujioka K, Kalish F, Zhao H, Lu S, Wong S, Wong RJ, Stevenson DK.

Shock. 2017 Feb;47(2):242-250. doi: 10.1097/SHK.0000000000000689.

PMID:
27454382
13.

Genotype 1 hepatitis E virus infection with acute acalculous cholecystitis as an extrahepatic symptom: a case report.

Fujioka K, Nishimura T, Seki M, Kinoshita M, Mishima N, Irimajiri S, Yamato M.

Trop Med Health. 2016 Jun 15;44:18. doi: 10.1186/s41182-016-0016-7.

14.

The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy.

Fujioka K, Plodkowski R, O'Neil PM, Gilder K, Walsh B, Greenway FL.

Int J Obes (Lond). 2016 Sep;40(9):1369-75. doi: 10.1038/ijo.2016.67.

PMID:
27328752
15.

The influence of body size on the intermittent locomotion of a pelagic schooling fish.

Noda T, Fujioka K, Fukuda H, Mitamura H, Ichikawa K, Arai N.

Proc Biol Sci. 2016 Jun 15;283(1832). pii: 20153019. doi: 10.1098/rspb.2015.3019.

PMID:
27252017
16.

Understanding the Capacity for Exercise in Post-Bariatric Patients.

Coleman KJ, Caparosa SL, Nichols JF, Fujioka K, Koebnick C, McCloskey KN, Xiang AH, Ngor EW, Levy SS.

Obes Surg. 2017 Jan;27(1):51-58. doi: 10.1007/s11695-016-2240-y.

PMID:
27229736
17.

Improvements in health-related quality of life with liraglutide 3.0 mg compared with placebo in weight management.

Kolotkin RL, Fujioka K, Wolden ML, Brett JH, Bjorner JB.

Clin Obes. 2016 Aug;6(4):233-42. doi: 10.1111/cob.12146.

18.

Ultrasound follow-up in a patient with intestinal obstruction due to post-traumatic intramural duodenal hematoma.

Homma Y, Mori K, Ohnishi Y, Fujioka K, Terada T, Sasaki A, Nagai T, Inoue M.

J Med Ultrason (2001). 2016 Jul;43(3):431-4. doi: 10.1007/s10396-016-0717-x.

PMID:
27194436
19.

The Powdering Process with a Set of Ceramic Mills for Green Tea Promoted Catechin Extraction and the ROS Inhibition Effect.

Fujioka K, Iwamoto T, Shima H, Tomaru K, Saito H, Ohtsuka M, Yoshidome A, Kawamura Y, Manome Y.

Molecules. 2016 Apr 11;21(4):474. doi: 10.3390/molecules21040474.

20.

Abnormal number cell division of human thyroid anaplastic carcinoma cell line, SW 1736.

Ikeda K, Tachibana T, Suzuki Y, Fujioka K, Takeyama H, Manome Y.

Data Brief. 2015 Oct 9;5:396-8. doi: 10.1016/j.dib.2015.09.030.

Items per page

Supplemental Content

Loading ...
Support Center